Latest China Cybersecurity Proposal Could Impose Heightened Scrutiny On Biopharma
Executive Summary
Drugmaking is among key information infrastructure industries likely subject to additional security and reporting obligations under draft legislation, adding costs and even potentially causing business disruptions, legal experts say.